It was made to replicate ghrelin’s effects in the intestinal tract to facilitate peristalsis [32, 33] Developed by Theratechnologies, this peptide particularly resolves lipodystrophy in HIV/AIDS people via upregulation of GH, which is known to decrease excess stomach and visceral fat [29] As a result of its efficacy, the peptide gained FDA authorization in 2010
